ImmunoPrecise identifies SARS-CoV-2 neutralizing antibodies

By The Science Advisory Board staff writers

June 29, 2020 -- ImmunoPrecise Antibodies has identified several lead candidate antibodies with high neutralizing activity in vitro that are being manufactured for further testing and possible inclusion in the company's PolyTope monoclonal antibody therapy against COVID-19.

The selected lead antibodies are the result of functional screening of over 300 antibodies analyzed from human and llama cells utilizing proprietary phage display technology. These antibodies support the company's goal of generating a multitarget therapy that retains efficacy, even as SARS-CoV-2 continues to evolve.

The company is preparing to test the lead antibodies against additional mutated strains of the virus with preclinical studies slotted to begin this summer.

Yumab spinoff Corat to develop COVID-19 drug
Yumab has announced that the first financing round of its spinoff Corat Therapeutics will be used to advance the development of COVID-19 antibody drug...
Regeneron begins clinical trials for COVID-19 antibody treatment
Regeneron Pharmaceuticals has started its first clinical trial investigating an antibody treatment for COVID-19.
Integral Molecular aids with safety testing of COVID-19 antibodies
Integral Molecular is applying its membrane proteome array technology for antibody specificity profiling to accelerate development of SARS-CoV-2 therapeutic...
Oblique Therapeutics identifies epitope for SARS-CoV-2 antibodies
Oblique Therapeutics has used its Abiprot antibody discovery platform to identify an epitope in SARS-CoV-2 that may facilitate the generation of new neutralizing...

Copyright © 2020 scienceboard.net


Conferences
Microscopy and Microanalysis Meeting
July 31 - August 4
Portland, Oregon United States
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter